Atomo DiagnosticsASX:AT1 PB Ratio is 2.13 as of Jun. 27, 2026, which is 29% above its 10-year median of 1.65. The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, Atomo Diagnostics ranks worse than 51.27% on this metric.
The historical rank and industry rank for Atomo Diagnostics's PB Ratio or its related term are showing as below:
ASX:AT1'
s PB Ratio Range Over the Past 10 Years
Min: 0.49 Med: 1.65 Max: 7.3
Current: 2.13
During the past 6 years, Atomo Diagnostics's highest PB Ratio was 7.30. The lowest was 0.49. And the median was 1.65.
ASX:AT1's PB Ratio is ranked worse than 51.27% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 2.02
vs ASX:AT1: 2.13
During the past 12 months, Atomo Diagnostics's average Book Value Per Share Growth Rate was -33.30% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -40.60% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -32.30% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Atomo Diagnostics was -24.70% per year. The lowest was -40.60% per year. And the median was -32.90% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Atomo Diagnostics PB Ratio Related Terms
Atomo Diagnostics PB Ratio Historical Data
* Premium members only.
The historical data trend for Atomo Diagnostics's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Atomo Diagnostics's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Atomo Diagnostics PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Atomo Diagnostics's PB Ratio distribution charts can be found below:
* The bar in red indicates where Atomo Diagnostics's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Atomo Diagnostics (ASX:AT1) has a PB Ratio of 2.13 as of Jun. 27, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Atomo Diagnostics and its competitors. This is 29% above median its historical median of 1.65. Over the past decade, Atomo Diagnostics' PB Ratio has ranged from 0.49 to 7.30. According to the industry distribution chart, Atomo Diagnostics ranks #404 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 51.3%.
Is Atomo Diagnostics' PB Ratio too high?
Atomo Diagnostics' current PB Ratio of 2.13 is 29% above median its 10-year median of 1.65. Over the past 10 years, this metric has ranged from a low of 0.49 to a high of 7.30. The Medical Devices & Instruments industry median PB Ratio is 2.02. Atomo Diagnostics' value of 2.13 is 5.4% above this industry median. Based on the distribution chart, Atomo Diagnostics ranks #404 out of 788 companies in the Medical Devices & Instruments industry, which is below the industry midpoint.
How does Atomo Diagnostics' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Atomo Diagnostics ranks #404 out of 788 companies for PB Ratio. This places Atomo Diagnostics in the lower half of its industry. The industry median PB Ratio is 2.02. Atomo Diagnostics' value of 2.13 is 5.4% above this benchmark. Historically, Atomo Diagnostics' own PB Ratio has ranged from 0.49 to 7.30 over the past decade. While the company's 10-year median is 1.65 vs. the industry median of 2.02, Atomo Diagnostics has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.02, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Atomo Diagnostics's current PB Ratio of 2.13 is 5.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Atomo Diagnostics and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Atomo Diagnostics's current PB Ratio is 2.13, which is 29% above median its own 10-year median of 1.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Atomo Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Atomo Diagnostics (ASX:AT1) is currently considered Modestly Undervalued. The stock's GF Value™ is A$0.02, compared to a current price of A$0.02 — trading 15% below its estimated fair value. The current PB Ratio is 2.13, which is 29% above median its 10-year median of 1.65 and 5.4% above the Medical Devices & Instruments industry median of 2.02. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Atomo Diagnostics (ASX:AT1), the current PB Ratio is 2.13 as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Atomo Diagnostics Ltd is an Australian medical device design innovator and original equipment manufacturing company. The company is engaged in the development and sale of medical devices. The company develops point-of-care devices for rapid diagnostic testing. The company offers AtomoRapid RDT Platform with devices including Galileo, Pascal, Curie, and Elion. The firm operates in a single segment, medical device research and development.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:AT1 has been successfully added to your 